Obinutuzumab (anti-CD20)
A2023
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameObinutuzumab (anti-CD20) [949142-50-1]
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionObinutuzumab (anti-CD20) (Gazyva, GA101, Gazyvaro, Afutuzumab) is a novel, type II, glycoengineered, humanized anti-CD20 monoclonal antibody that has been developed for lymphocytic leukemia and lymphoma of B-cell origin. MW : 146.1 kD.
- Storage Instruction2°C to 8°C
- UNSPSC12352203